Skip to content

13F-HR filed by Iron Triangle Partners LP

Iron Triangle Partners LP filed this 13F-HR for the quarter ended 2021-03-31, filed 2021-05-17, with 27 holding rows worth $786,489,000.

Accession
0001172661-21-001204
Filed
2021-05-17
Accepted by EDGAR
acceptance time not in the bulk data set
Ingested
Source
SEC quarterly data set

Original filing

13F report for Q1 2021

A holdings report, 27 entries on the cover page, a total value of $786,489,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $786,489,000 with VALUE read as thousands by filing date, 13F file number 028-20024. The quarter's positions are built on this report. The resolved quarter.

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
ENCOMPASS HEALTH CORP COM29261A100Stock775,000$63,473,000thousands by filing date
UnitedHealth Group Inc91324P102COM160,000$59,531,000thousands by filing date
ZIMMER BIOMET HOLDINGS INC COM98956P102Stock370,000$59,230,000thousands by filing date
MOLINA HEALTHCARE INC60855R100COM200,000$46,752,000thousands by filing date
HORIZON THERAPEUTICS PLCG46188101SHS500,000$46,020,000thousands by filing date
LABORATORY CORP OF AMERICA50540R409COM NEW170,000$43,355,000thousands by filing date
CHARLES RIV LABS INTL INC159864107COM140,000$40,576,000thousands by filing date
ALIGN TECHNOLOGY INC COM016255101Stock70,000$37,907,000thousands by filing date
ENVISTA HOLDINGS CORPORATION29415F104COM910,000$37,128,000thousands by filing date
HAEMONETICS CORP MASS COM405024100Stock330,000$36,633,000thousands by filing date
AbbVie,Inc.00287Y109COM300,000$32,466,000thousands by filing date
SURGERY PARTNERS INC86881A100COM725,000$32,089,000thousands by filing date
PACIFIC BIOSCIENCES CALIF INC COM69404D108Stock935,805$31,172,000thousands by filing date
PULMONX CORP745848101COM600,000$27,444,000thousands by filing date
CONMED CORP COM207410101Stock200,000$26,118,000thousands by filing date
NEVRO CORP64157F103COM180,000$25,110,000thousands by filing date
IQVIA HLDGS INC COM46266C105Stock100,000$19,314,000thousands by filing date
OAK STR HEALTH INC67181A107COM350,000$18,995,000thousands by filing date
IDEXX LABS INC COM45168D104Stock35,000$17,126,000thousands by filing date
GUARDANT HEALTH INC COM40131M109Stock100,000$15,265,000thousands by filing date
NATERA INC COM632307104Stock150,000$15,231,000thousands by filing date
EXACT SCIENCES CORP COM30063P105Stock100,000$13,178,000thousands by filing date
DERMTECH INC24984K105COM250,000$12,698,000thousands by filing date
ORION ACQUISITION CORP68626A207UNIT 02/19/20261,100,000$10,989,000thousands by filing date
VERICEL CORP92346J108COM160,000$8,888,000thousands by filing date
OUTSET MEDICAL INC690145107COM100,000$5,439,000thousands by filing date
ROYALTY PHARMA PLCG7709Q104SHS CLASS A100,000$4,362,000thousands by filing date

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0001172661-21-001204this filing2021-05-17acceptance time not in the bulk data set